IntelliSpace Cognition

Informing your clinical judgment

of cognitive impairment

Supporting your patient care


Changes in memory and cognition have become common concerns for neurology practices globally (Bailey et al 2018; Herman et al 2017; Gino et al 2010; Pires et al 2012). Such issues likely stem from heightened public awareness about Alzheimer’s disease and related dementias (ADRD), as well as collective knowledge that cognitive impairment can be detected early and prior to loss of daily functions. Although the desire to evaluate and understand cognitive function is top of mind in many clinical interactions, neurologists face a number of barriers when seeking comprehensive analyses of cognitive testing, education, and interventions.

 

Cognitive concerns and objective impairment on testing are common for a wide range of medical and neurologic conditions, apart from ADRD (Grzegorski et al 2017; Vuralli et al 2018; Witt et al 2017; Zilliox et al 2016). Due to time limitations and lack of knowledge on how to best evaluate and address cognition in disorders such as MS, TBI, epilepsy, and stroke, neurologists may naturally focus on diagnosing and treating the “primary” disease(s) rather than the “secondary” cognitive difficulties that may be major contributors to loss of function or decreased quality of life. When cognitive changes are the “primary” symptom, like in ADRD or ADHD, addressing and treating cognition is considered the standard of care (Sanders et al 2017).

 

In a myriad of other conditions, however, guidelines and priorities about assessing cognition are not well documented. Additionally, patterns of cognitive deficits are less pathognomonic than in ADRD and often not part of diagnostic criteria or longitudinal care recommendations.

 

Yet, even with ample time to evaluate and intervene on cognition, neurologists may also lack adequate resources to effectively test for, educate about, and make recommendations on impairment. Some neurologists rely on colleagues in neuropsychology to administer and interpret formal assessments. However, access to and quality of these services can vary and may be beset by long wait times, poor patient experience, lengthy and inefficient testing, or geographic limitations (Allott et al 2009; Miller et al 2017). Fifty percent of neurologists think the average wait time for a cognitive assessment, whether by a neurologist or neuropsychologist, has a negative impact on diagnosis and treatment.* Other neurologists may not feel comfortable with the ever-changing, neurologic subspecialty knowledge on cognitive testing or possible intervention options.

 

These barriers highlight a notable gap in cognitive evaluation and treatment, limiting neurologists’ ability to provide optimal care to patients. To overcome limitations, one necessary step is to involve additional cognitive care education for neurologists and support staff. An equally important solution is to adopt better tools to obtain timely, evidence-based neurocognitive assessment in everyday practice — even in patients who might otherwise not be assessed.

 

Working with neuropsychologists and neurologists, Philips is developing a new digital cognitive assessment platform featuring a battery of well-established tests and providing automated scoring, cognitive domain mapping, and basic interpretation. A primary goal of this platform is to enable robust and reliable cognitive assessment with far greater efficiency and scale than traditional methods. The emergence of digital platforms that combine the best of traditional neuropsychological assessment with cutting-edge automation and adaptive intelligence has the potential to meaningfully transform neurologists’ diagnosis and treatment for excellent patient care.

 

For more information, please visit our website.

 

*From an online survey of 75 US-based neurologists; commissioned by Philips and conducted by MarkTech Group

References


Ginó S, Mendes T, Maroco J, Ribeiro F, Schmand BA, de Mendonça A, Guerreiro M. Memory complaints are frequent but qualitatively different in young and elderly healthy people. Gerontology. 2010;56(3):272-7. doi: 10.1159/000240048. Epub 2009 Sep 17. PubMed PMID: 19776545.

 

Bailey C, Poole N, Blackburn DJ. Identifying patterns of communication in patients attending memory clinics: a systematic review of observations and signs with potential diagnostic utility. Br J Gen Pract. 2018 Feb;68(667):e123-e138. doi: 10.3399/bjgp18X694601. Epub 2018 Jan 15. PubMed PMID: 29335322; PubMed Central PMCID: PMC5774964.

 

Pires C, Silva D, Maroco J, Ginó S, Mendes T, Schmand BA, Guerreiro M, de Mendonça A. Memory complaints associated with seeking clinical care. Int J Alzheimers Dis. 2012;2012:725329. doi: 10.1155/2012/725329. Epub 2012 Mar 24. PubMed PMID: 22536537; PubMed Central PMCID: PMC3320051.

 

Grzegorski T, Losy J. Cognitive impairment in multiple sclerosis - a review of current knowledge and recent research. Rev Neurosci. 2017 Nov 27;28(8):845-860. doi: 10.1515/revneuro-2017-0011. Review. PubMed PMID: 28787275.

 

Vuralli D, Ayata C, Bolay H. Cognitive dysfunction and migraine. J Headache Pain. 2018 Nov 15;19(1):109. doi: 10.1186/s10194-018-0933-4. Review. PubMed PMID: 30442090. 

 

Witt JA, Helmstaedter C. Cognition in epilepsy: current clinical issues of interest. Curr Opin Neurol. 2017 Apr;30(2):174-179. doi: 10.1097/WCO.0000000000000430. Review. PubMed PMID: 28118301

 

Zilliox LA, Chadrasekaran K, Kwan JY, Russell JW. Diabetes and Cognitive Impairment. Curr Diab Rep. 2016 Sep;16(9):87. doi: 10.1007/s11892-016-0775-x. Review. PubMed PMID: 27491830; PubMed Central PMCID: PMC5528145.

 

Sanders AE, Nininger J, Absher J, Bennett A, Shugarman S, Roca R. Quality improvement in neurology: Dementia management quality measurement set update. Neurology. 2017 May 16;88(20):1951-1957. doi: 10.1212/WNL.0000000000003917. Epub 2017 May 1. PubMed PMID: 28461640.

 

Allott K, Lloyd S. The provision of neuropsychological services in rural/regional settings: professional and ethical issues. Appl Neuropsychol. 2009 Jul;16(3):193-206. doi: 10.1080/09084280903098760. PubMed PMID: 20183172. 

 

Miller JB, Barr WB. The Technology Crisis in Neuropsychology. Arch Clin Neuropsychol. 2017 Aug 1;32(5):541-554. doi: 10.1093/arclin/acx050. Review. PubMed PMID: 28541383.

 

Herman L, Atri A, Salloway S. Alzheimer's Disease in Primary Care: The Significance of Early Detection, Diagnosis, and Intervention. Am J Med. 2017 Jun;130(6):756. doi: 10.1016/j.amjmed.2017.04.001. Epub 2017 Apr 25. PubMed PMID: 28449849.